Reaction

Chronic Respiratory Failure reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,175 reports · 50 co-occurring drugs

As of the last recalculation, Chronic Respiratory Failure appears in 1,175 FAERS reports alongside 50 co-occurring drug terms. The strongest observed disproportionality signal is 0XYGEN (PRR 39.6).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
0Xygen	101	39.6	39.7
Oxygen	101	39.6	39.7
Nintedanib	57	33.8	33.8
Epoprostenol	22	30.3	30.4
Sildenafil Powder,	46	23.8	23.8
Bosentan	63	23.3	23.4
Amiodarone Hydrochloride	13	20.8	20.8
Polyethylene Glycol	12	19.8	19.8
Sildenafil	60	19.3	19.3
Budesonide, Glycopyrrolate, And Formoterol Fumarate	11	18.8	18.8
Macitentan	68	18.4	18.4
Metolazone	11	17.5	17.5
Bumetanide	25	17.1	17.1
Captopril	9	16.7	16.7
Riociguat	30	16.7	16.7
Theophylline Anhydrous	11	15.9	15.9
Nystatin	24	15.9	15.9
Naproxen Sodium, Dextromethorphan Hydrobromide, Guaifenesin	17	14.8	14.9
Naproxen Sodium, Pseudoephedrine Hydrochloride	17	14.8	14.8
Sildenafil Citrate	97	14.6	14.6
Guaifenesin	24	14.2	14.2
Tobramycin	19	14.2	14.2
Theophylline	9	14.0	14.0
Palivizumab	12	14.0	14.0
Treprostinil	91	13.8	13.8
Amikacin	13	13.6	13.6
Pirfenidone	30	13.4	13.4
Piperacillin Sodium And Tazobactam Sodium	14	12.8	12.8
Ambrisentan	80	12.1	12.1
Umeclidinium	6	11.9	11.9
Selexipag	15	10.4	10.4
Tobramycin Solution	7	10.4	10.4
Miconazole Nitrate	5	10.2	10.2
Dofetilide	6	10.2	10.2
Tobramycin Sulfate	7	10.1	10.1
Cefepime	8	9.9	10.0
Benzonatate	9	9.7	9.7
Pyrazinamide	5	9.5	9.5
Fluticasone Propionate And Salmeterol	20	8.6	8.6
Norepinephrine	5	8.3	8.3
Remdesivir	6	8.0	8.0
Mometasone Furoate And Formoterol Fumarate Dihydrate	7	8.0	8.0
Tiotropium Bromide Inhalation Spray	5	7.9	7.9
Fluticasone Furoate, Umeclidinium Bromide And Vilanterol Trifenatate	16	6.9	6.9
Lumacaftor And Ivacaftor	3	6.2	6.2
Vigabatrin	5	6.1	6.1
Cannabidiol	8	6.1	6.1
Umeclidinium Bromide And Vilanterol Trifenatate	5	5.3	5.3
Durvalumab	6	5.2	5.2
Dornase Alfa	4	3.6	3.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.